Literature DB >> 17515481

MicroRNAs in human cancer: from research to therapy.

Massimo Negrini1, Manuela Ferracin, Silvia Sabbioni, Carlo M Croce.   

Abstract

Numerous miRNAs are deregulated in human cancers, and experimental evidence indicates that they can play roles as oncogenes or tumor suppressor genes. Similarly to cancer genes that encode proteins, deregulation of miRNA-encoding genes is associated with genetic or epigenetic alterations, such as deletions, amplifications, point mutations and aberrant DNA methylation. The discovery that miRNAs interact with known oncogenes has established further links with molecular pathways implicated in malignant transformation. Finally, miRNAs can be used as diagnostic markers, and their potential as therapeutic molecules has moved miRNAs from the area of basic research to the field of cancer biotechnology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515481     DOI: 10.1242/jcs.03450

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  89 in total

1.  Epigenetic changes induced by curcumin and other natural compounds.

Authors:  Simone Reuter; Subash C Gupta; Byoungduck Park; Ajay Goel; Bharat B Aggarwal
Journal:  Genes Nutr       Date:  2011-04-24       Impact factor: 5.523

2.  Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues.

Authors:  Yuanming Shen; Yang Li; Feng Ye; Fenfen Wang; Xiaoyun Wan; Weiguo Lu; Xing Xie
Journal:  Exp Mol Med       Date:  2011-06-30       Impact factor: 8.718

3.  Oncogenic role of miR-483-3p at the IGF2/483 locus.

Authors:  Angelo Veronese; Laura Lupini; Jessica Consiglio; Rosa Visone; Manuela Ferracin; Francesca Fornari; Nicola Zanesi; Hansjuerg Alder; Gemma D'Elia; Laura Gramantieri; Luigi Bolondi; Giovanni Lanza; Patrizia Querzoli; Adriano Angioni; Carlo M Croce; Massimo Negrini
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

4.  Dynamic origins of differential RNA binding function in two dsRBDs from the miRNA "microprocessor" complex.

Authors:  Christopher Wostenberg; Kaycee A Quarles; Scott A Showalter
Journal:  Biochemistry       Date:  2010-11-22       Impact factor: 3.162

Review 5.  Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets.

Authors:  Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Adv Anat Pathol       Date:  2008-11       Impact factor: 3.875

6.  Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.

Authors:  Neveen Abd El Moneim Hussein; Zenat A El Kholy; Medhat M Anwar; Mohamed A Ahmad; Shaymaa M Ahmad
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-15       Impact factor: 4.553

7.  Maximization of loading and stability of ssDNA:iron oxide nanoparticle complexes formed through electrostatic interaction.

Authors:  Lorenzo Berti; Temesgen Woldeyesus; Yuanpei Li; Kit S Lam
Journal:  Langmuir       Date:  2010-11-03       Impact factor: 3.882

8.  Mutated beta-catenin evades a microRNA-dependent regulatory loop.

Authors:  Angelo Veronese; Rosa Visone; Jessica Consiglio; Mario Acunzo; Laura Lupini; Taewan Kim; Manuela Ferracin; Francesca Lovat; Elena Miotto; Veronica Balatti; Lucilla D'Abundo; Laura Gramantieri; Luigi Bolondi; Yuri Pekarsky; Danilo Perrotti; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

9.  miR-216a-5p acts as an oncogene in renal cell carcinoma.

Authors:  Peijie Chen; Jing Quan; Lu Jin; Canbin Lin; Weijie Xu; Jinling Xu; Xin Guan; Zebo Chen; Liangchao Ni; Shangqi Yang; Yun Chen; Yongqing Lai
Journal:  Exp Ther Med       Date:  2018-02-20       Impact factor: 2.447

10.  Advances in the mechanisms of action of cancer-targeting oncolytic viruses.

Authors:  Cun-Zhi Lin; Gui-Ling Xiang; Xin-Hong Zhu; Lu-Lu Xiu; Jia-Xing Sun; Xiao-Yuan Zhang
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.